Xtl Biopharmaceuticals Ltd financial data

Symbol: XTLB on Nasdaq
Industry: Pharmaceutical Preparations
Location: Xtl Biopharmaceuticals Ltd, C/O Alston & Bird Llp, 90 Park Avenue, New York, NY
State of incorporation: Israel
Latest financial report: 20-F - Q4 2022 - Mar 22, 2023

Shares

Label	TTM Value / Value	Unit	Change %	Calendar period	Fiscal period
Entity Common Stock, Shares Outstanding	545M	shares	0%	Q4 2022	FY 2022

Income Statement

Label	TTM Value / Value	Unit	Change %	Calendar period	Fiscal period
Research And Development Expense	15K	USD	+150%	Q2 2022	Q2 2022
General And Administrative Expense	187K	USD	-37%	Q2 2022	Q2 2022

Balance Sheet

Label	TTM Value / Value	Unit	Change %	Calendar period	Fiscal period
Assets	4.19M	USD	-36.7%	Q4 2022	FY 2022